Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The complement system in central nervous system diseases.

Horea Rus1, Cornelia Cudrici, Stefan David

  • 1Department of Neurology, School of Medicine, University of Maryland, Baltimore, MD 21201, USA. hrus@umaryland.edu

Autoimmunity
|August 23, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Longitudinal <i>in vivo</i> human wound healing model defines key role for smooth muscle cells in ECM remodeling.

bioRxiv : the preprint server for biology·2026
Same author

Behavior of Complement System Effectors in Chronic and Acute Coronary Artery Disease.

Journal of clinical medicine·2025
Same author

Multiple sclerosis disease activity, a multi-biomarker score of disease activity and response to treatment in multiple sclerosis.

Frontiers in immunology·2024
Same author

The liver and muscle secreted HFE2-protein maintains central nervous system blood vessel integrity.

Nature communications·2024
Same author

COVID, complement, and the brain.

Frontiers in immunology·2023
Same author

Implementing a multidimensional perioperative delirium curriculum for surgical residents.

Journal of the American Geriatrics Society·2022

The complement system, crucial in brain diseases, offers neuroprotection by enhancing oligodendrocyte survival and clearing harmful proteins. Its role in injury and protection depends on the specific disease context.

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • The complement system is implicated in inflammatory, neurodegenerative, and cerebrovascular diseases.
  • Central nervous system (CNS) cells can synthesize complement components.
  • Myelin and oligodendrocytes (OLG) activate the complement classical pathway in vitro without antibodies.

Purpose of the Study:

  • To investigate the dual role of complement system activation in CNS diseases.
  • To explore the neuroprotective potential of complement activation, particularly terminal C5b-9 complexes.
  • To understand the context-dependent effects of complement activation in brain injury and neurodegeneration.

Main Methods:

  • In vitro studies on oligodendrocyte survival.
  • In vivo studies on complement activation.

Related Experiment Videos

  • Analysis of complement system involvement in neurodegenerative and cerebrovascular disease models.

    • Main Results:

    • Terminal C5b-9 complexes promote oligodendrocyte survival both in vitro and in vivo.
    • Complement activation may aid in clearing amyloid and degenerating neurons.
    • Complement system activation is involved in brain damage following ischemic injury and head trauma.

    Conclusions:

    • Complement activation can exert both detrimental and beneficial effects in the CNS.
    • Terminal C5b-9 complexes demonstrate neuroprotective capabilities, enhancing OLG survival.
    • The specific pathophysiological context dictates whether complement activation leads to injury or neuroprotection.